About: http://webisa.webdatacommons.org/267200934

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	In addition, we are developing reagents including antibodies, peptides and small molecules designed to specifically disrupt the Cripto/GRP78 interface.
http://www.w3.org/ns/prov#wasQuotedFrom	salk.edu